[Zocor and Sotacor]

[Zocor and Sotacor] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Zocor and Sotacor] Abstract Text:

[Zocor and Sotacor] Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Zocor and Sotacor] Journal Published:

PUBLICATION TYPE: Letter

Journal: Tidsskrift for den Norske lægeforening : tidsskrif

VOLUME: 117

Page Numbers: 1187

Journal Abbreviation: Tidsskr. Nor. Laegeforen.

ISSN: 0029-2001

DAY: 20

MONTH: Mar

YEAR: 1997

[Zocor and Sotacor] Information

Number of References:

LANGUAGE: nor

NlmUniqueID: 413423

[Zocor and Sotacor] Keywords Mesh Terms:

KEYWORDS: Terminology as Topic

MESH TERMS: administration & dosage

Chemical & Substance for Abstract: [Zocor and Sotacor] Information

Substance Name: Simvastatin

Registry Number: 79902-63-9

Grant and Affiliation Information for [Zocor and Sotacor]

AFFILIATION:

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Tidsskr Nor Laegeforen

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Zocor and Sotacor Related Publications

• Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men.
• Effect of Orlistat on Eating Behavior Among Participants in a 3-year Weight Maintenance Trial.
• Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease.
• Identifying obese women most at risk from cardiovascular disease.
• Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study.
• The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders.
• Validation of ActiReg(R) to measure physical activity and energy expenditure against doubly labelled water in obese persons.
• [Antioxidants and cardiovascular disorders--epidemiologic aspects. Should high risk patients receive supplementation?]
• [Biotechnology and familial hypercholesterolemia]
• [Diet and secondary prevention of coronary heart disease--are our recommendations good enough?]
• [Dietary supplementation in the treatment of hyperlipidemia]
• [Do women need different strategies than men to prevent cardiovascular diseases?]
• [Drug therapy of hyperlipidemia--unanswered questions]
• [Hormone replacement therapy in menopause and cardiovascular disease--one more time]
• [New trends in the treatment of obesity]
• [Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis]
• [Zocor and Sotacor]